These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 36877351)

  • 1. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo Pathway in Prostate Cancer.
    Salem O; Hansen CG
    Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of signaling pathways regulating YAP/TAZ activity.
    Heng BC; Zhang X; Aubel D; Bai Y; Li X; Wei Y; Fussenegger M; Deng X
    Cell Mol Life Sci; 2021 Jan; 78(2):497-512. PubMed ID: 32748155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
    Patel SH; Camargo FD; Yimlamai D
    Gastroenterology; 2017 Feb; 152(3):533-545. PubMed ID: 28003097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.
    Kim MH; Kim J
    Cell Mol Life Sci; 2017 Apr; 74(8):1457-1474. PubMed ID: 27826640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ at the Roots of Cancer.
    Zanconato F; Cordenonsi M; Piccolo S
    Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAP2 mediates mechanoresponses of the Hippo pathway.
    Meng Z; Qiu Y; Lin KC; Kumar A; Placone JK; Fang C; Wang KC; Lu S; Pan M; Hong AW; Moroishi T; Luo M; Plouffe SW; Diao Y; Ye Z; Park HW; Wang X; Yu FX; Chien S; Wang CY; Ren B; Engler AJ; Guan KL
    Nature; 2018 Aug; 560(7720):655-660. PubMed ID: 30135582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of YAP/TAZ in ferroptosis.
    Magesh S; Cai D
    Trends Cell Biol; 2022 Sep; 32(9):729-732. PubMed ID: 35701310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity.
    Yuan B; Liu J; Shi A; Cao J; Yu Y; Zhu Y; Zhang C; Qiu Y; Luo H; Shi J; Cao X; Xu P; Shen L; Liang T; Zhao B; Feng XH
    EMBO J; 2023 Feb; 42(4):e111549. PubMed ID: 36598329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer.
    Patterson MR; Cogan JA; Cassidy R; Theobald DA; Wang M; Scarth JA; Anene CA; Whitehouse A; Morgan EL; Macdonald A
    Nat Commun; 2024 Jul; 15(1):5809. PubMed ID: 38987584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
    Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
    BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging roles of YAP and TAZ in cancer.
    Moroishi T; Hansen CG; Guan KL
    Nat Rev Cancer; 2015 Feb; 15(2):73-79. PubMed ID: 25592648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ.
    Xekouki P; Lodge EJ; Matschke J; Santambrogio A; Apps JR; Sharif A; Jacques TS; Aylwin S; Prevot V; Li R; Flitsch J; Bornstein SR; Theodoropoulou M; Andoniadou CL
    Endocr Relat Cancer; 2019 Jan; 26(1):215-225. PubMed ID: 30139767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.